Delivery Order SPE2DE21D7009-SPE2D626F7A99
- Not listed
- Boston Scientific Neuromodulation Corp, a subsidiary of Boston Scientific Corporation, received a delivery order valued at $31,806.25 for pain management medical devices on November 28, 2025, with an ultimate completion date of December 17, 2025. This fixed-price delivery order with economic price adjustment was issued by the Defense Logistics Agency's Medical Supply Chain division under the company's larger indefinite delivery contract (SPE2DE), valued at $83.1 million through August 16,...
- Boston Scientific Neuromodulation Corp, a subsidiary of Boston Scientific Corporation, was awarded a delivery order valued at $1,867.00 on December 15, 2025, for pain management medical devices and services. This fixed-price contract with economic price adjustment authority has an ultimate completion date of February 6, 2026, and will be performed in Valencia, California. The award was made without a set-aside designation by the Medical Supply Chain, a defense-related procurement entity within...
- Boston Scientific Neuromodulation Corp, a subsidiary of Boston Scientific Corp, received a $1,867 fixed-price delivery order with economic price adjustment authority for pain management medical devices, with a completion date of March 2, 2026. The contract was awarded on December 15, 2025, by the Medical Supply Chain, a defense-related procurement entity within the Department of Defense. Work will be performed at the company's facility in Valencia, California. This delivery order is issued under...
- Boston Scientific Neuromodulation Corp, a subsidiary of Boston Scientific Corporation, received a $31,798.00 fixed-price delivery order with economic price adjustment for pain management medical devices, awarded December 31, 2025, with an ultimate completion date of March 2, 2026. This delivery order, issued without a small business set-aside, is funded by the Defense Logistics Agency's Medical Supply Chain division and will be performed at the contractor's Valencia, California facility. The...
- Boston Scientific Neuromodulation Corp, a subsidiary of Boston Scientific Corp, was awarded a fixed-price delivery order valued at $43,709.82 on December 15, 2025, for pain management medical devices and equipment. The delivery order, with a ultimate completion date of December 22, 2025, will be performed in Valencia, California, and is funded by the Defense Logistics Agency's Medical Supply Chain, a defense-related procurement entity within the Department of Defense. This award carries no small...
- Boston Scientific Neuromodulation Corp, a subsidiary of Boston Scientific Corp, was awarded a $26,980 fixed-price delivery order with economic price adjustment on November 28, 2025, under contract 4570237140 for pain management medical devices and services. The order, with an ultimate completion date of December 5, 2025, represents work to be performed in Valencia, California, and is funded by the Defense Logistics Agency's Medical Supply Chain division. This delivery order is issued under the...
- Boston Scientific Neuromodulation Corp, a subsidiary of Boston Scientific Corporation, has been awarded a fixed-price delivery order valued at $31,408.96 for pain management medical devices and equipment. The contract, awarded on July 24, 2025, with an ultimate completion date of July 31, 2025, carries no set-aside designation and will be performed in Valencia, California. The award is funded by the Medical Supply Chain, a defense-related procurement entity within the Department of Defense,...
- Boston Scientific Neuromodulation Corp, a subsidiary of Boston Scientific Corporation, was awarded a delivery order valued at $31,877.20 on December 15, 2025, for pain management medical devices and services. This fixed-price contract with economic price adjustment has a completion date of December 29, 2025, and will be performed in Valencia, California. The award carries no small business set-aside designation and is funded by the Medical Supply Chain, a defense-related procurement entity...
- The Department of Defense's Defense Logistics Agency Troop Support Medical awarded a $1,709.00 fixed price delivery order to Boston Scientific Neuromodulation Corp, a subsidiary of Boston Scientific Corp, for pain management products and services. The contract has no set-aside designation. This order is part of a larger $83 million single-award indefinite delivery contract Boston Scientific Neuromodulation holds with DLA Troop Support Medical to provide spinal cord stimulation equipment and...
- Boston Scientific Neuromodulation Corp, a subsidiary of Boston Scientific Corporation, has been awarded a delivery order valued at $1,838.13 for pain management medical devices under a fixed-price contract with economic price adjustment provisions. The award, issued on November 28, 2025, with an ultimate completion date of December 17, 2025, is funded by the Defense Logistics Agency's Medical Supply Chain division, a defense-related procurement entity supporting the Department of Defense. The...
- SPE2DE21D7009Indefinite Delivery Contract
- SPE2DE21D7009-SPE2D626F7A99Delivery Order
The Defense Logistics Agency Troop Support Medical branch awarded a delivery order valued at $42,752.40 to Boston Scientific Neuromodulation Corp on December 31, 2025, for the delivery of a Kit NRSTM WaveWriter Alpha with 10.7mm thickness (quantity 200). This fixed-price delivery order with economic price adjustment provisions is scheduled for completion by March 30, 2026, and will be performed at the contractor's facility in Valencia, California. The award carries no small business set-aside designation, allowing Boston Scientific Neuromodulation to compete on an unrestricted basis as the awardee. This delivery order is issued under Boston Scientific Neuromodulation Corp's larger single-award indefinite delivery contract (SPE2DE) with the Defense Logistics Agency, valued at $83.1 million through August 16, 2026, which provides comprehensive neuromodulation solutions including spinal cord stimulation systems, implantable pain management devices, and associated accessories to military treatment facilities and Veterans Affairs medical centers nationwide. The WaveWriter Alpha represents an advanced spinal cord stimulation system designed to deliver non-opioid pain management therapies to service members and veterans managing chronic pain from traumatic injuries, supporting the Defense Department's strategic emphasis on reducing opioid dependence within military healthcare.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $42.8k | 12/30/25 |